Oxidative status assessment is an initial step in tumor related studies. To the best of our knowledge, this is the first study consider ing oxidative activity of both serum and tissue specimens in human basal cell carcinoma (BCC), which is the most common tumor in the world. Concentration of Malondialdehide (MDA) in human basal cell carcinoma (BCC) and individually matched normal skin tissue w ere examined with spectrophotometery method. Fresh normal and can cerous skin paired tissue was obtained from 60 patients who underwent curative BCC resection at one center in Tehran (Razi hospital). Serum Concentration of Malondialdehide (MDA) in these patients and 55 normal subjects w ere also measured. MDA level in cancerous tissue of patients with skin BCC (1.0 ± 0.14 ng/g) was significantly (p = 0.001) higher than normal neighboring skin tissue (0.3 ± 0.07 ng/g). A remarkable (No t significant, P = 0.18) increase was found in the serum MDA level in patients with skin BCC (8.0 ± 2.3 ng/ml) in compar i son with the control subjects (7.3 ± 2.9 ng/ml). A significant positive correlation (r = 0.276, p = 0.03) was found between Serum MDA and skin tissue MDA for non-affected skin tissue (normal neighboring skin), whereas no significant correlation (p > 0.05) was found for cancerous tissue. Cut-point of 5.2 ng/ml of serum MDA concentration showed a screening sensitivity of 95%. There is an active oxidative process in BCC lesions. Serum MDA concentration can be used either as a screening test or a predictor for tissue MDA concentration .
S. J. Miller, “Aetiology and Pathogenesis of Basal Cell Carcinoma,” Clinical Dermatology, Vol. 13, No. 6, 1995, pp. 527-536. doi:10.1016/0738-081X(95)00062-K
C. S. Wong, R. C. Strange and J. T. Lear, “Basal Cell Carcinoma,” BMJ, Vol. 327, No. 7418, 2003, pp. 794-798. doi:10.1136/bmj.327.7418.794
J. Barry, S. F. Oon, R. Watson and L. Barnes, “The Management of Basal Cell Carcinomas,” Irish Medical Journal, Vol. 99, No. 6, 2006, pp. 179-181.
M. Dandurand, T. Petit, P. Martel and B. Guillot, “Management of Basal Cell Carcinoma in Adults Clinical Practice Guidelines,” European Journal of Dermatology, Vol. 16, No. 4, 2006, pp. 394-401.
N. D. Brougham, E. R. Dennett and S. T. Tan, “Non-Melanoma Skin Cancers in New Zealand—A Neglected Problem,” The New Zealand Medical Journal, Vol. 123, No. 1325, 2010, pp. 59-65.
H. Krueger, D. Williams, M. Chomiak and L. Trenaman, “The Economic Burden of Skin Cancer in Canada: Current and Projected,” H. Krueger & Associates Inc., Manitoba, 2010.
K. Moore and L. J. Roberts, “Measurement of Lipid Peroxidation,” Free Radical Research, Vol. 28, No. 6, 2008, pp. 659-671. doi:10.3109/10715769809065821
D. Del Rio, A. J. Stewart and N. Pellegrini, “A Review of Recent Studies on Malondialdehyde as Toxic Molecule and Biological Marker of Oxidative Stress,” Nutrition, Metabolism & Cardiovascular Diseases, Vol. 15, No. 4, 2005, pp. 316-328. doi:10.1016/j.numecd.2005.05.003
M. D. Pampanin, L. Camus, A. Gomiero, I. Marangon, E. Volpato and C. Nasci, “Susceptibility to Oxidative Stress of Muscles (Mytilus Galloprovincialis) in the Venice Lagoon (Italy),” Marine Pollution Bulletin, Vol. 50, No. 12, 2005, pp. 1548-1557. doi:10.1016/j.marpolbul.2005.06.023
M. Bekerecioglu, R. Aslan, S. Ugras, A. Kutluhan, R. Sekeroglu, N. Akpolat and M. Karakok, “Malondialdehyde Levels in Serum of Patients with Skin Cancer,” European Journal of Plastic Surgery, Vol. 21, No. 5, 1998, pp. 227-229. doi:10.1007/s002380050076
R. H. Chole, R. N. Patil, A. Basak, K. Palandurkar, R. Bhowate, “Estimation of Serum Malondialdehyde in Oral Cancer and Precancer and Its Association with Healthy Individuals, Gender, Alcohol, and Tobacco Abuse,” Journal of Cancer Research Therapy, Vol. 6, No. 4, 2010, pp. 487-491. doi:10.4103/0973-1482.77106
R. Ramya, S. Prakash and S. Sudha, “Assessment of Serum Malondialdehyde in Oral Squamous Cell Carcinoma Patients and Its Association with Tobacco Habits,” Journal of Pharmaceutical and Biomedical Sciences (JPBMS), Vol. 10, No. 16, 2011, pp. 1-3.
H. H. Ahmed, M. M. Hegazi, H. I. Abd-Alla, E. F. Eskander and M. S. Ellithey, “Antitumour and Antioxidant Activity of Some Red Sea Seaweeds in Ehrlich Ascites Carcinoma in Vivo,” Z Naturforsch C, Vol. 66, No. 1-2, 2011, pp. 367-376. doi:10.5560/ZNC.2011.66c0367
M. A. Choi, B. S. Kim and R. Yu, “Serum Antioxidative Vitamin Levels and Lipid Peroxidation in Gastric Carcinoma Patient,” Cancer Letters, Vol. 136, No. 1, 1999, pp. 89-93. doi:10.1016/S0304-3835(98)00312-7
A. Gonen?, Y. Ozkan, M. Torun and B. Simsek, “Plasma Malondialdehyde (MDA) Levels in Breast and Lung Cancer Patients,” Journal of Clinical Pharmacy and Therapeutics, Vol. 26, No. 2, 2001, pp. 141-144. doi:10.1046/j.1365-2710.2001.00334.x
F. McArdle, L. E. Rhodes, R. A. Parslew, G. L. Close, C. I. Jack, P. S. Friedmann and M. J. Jackson, “Effects of Oral Vitamin E and Beta-Carotene Supplementation on Ultraviolet Radiation-Induced Oxidative Stress in Human Skin,” American Journal of Clinical Nutrition, Vol. 80, No. 5, 2004, pp. 1270-1275.
S. Taysi, M. Koc, M. E. Büyükokuroglu, K. Altsnkaynak and Y. Nurisahin, “Melatonin Reduces Lipid Peroxidation and Nitric Oxide during Irradiation-Induced Oxidative Injury in the Rat Liver,” Pineal Research, Vol. 34, No. 3, 2003, pp. 173-177. doi:10.1034/j.1600-079X.2003.00024.x
K.-J. Hyeyoung, “Inhibitory Effects of α-and β-Carotene on Croton Oil-Induced or Enzymatic Lipid Peroxidation and Hydroperoxide Production in Mouse Skin Epidermis,” International Journal of Biochemistry, Vol. 25, No. 6, 1993, pp. 911-915.
M. Basu, A. Banerjee, U. K. Bhattacharya, A. Bishayee and M. Chatterjee, “Beta-Carotene Prolongs Survival, Decreases Lipid Peroxidation and Enhances Glutathione Status in Transplantable Murine Lymphoma,” Phytomedicine, Vol. 7, No. 2, 2000, pp. 151-159. doi:10.1016/S0944-7113(00)80088-4
L. Patrick, “Toxic Metals and Antioxidants: Part II the Role of Antioxidants in Arsenic and Cadmium Toxicity,” Alternative Medicine Review, Vol. 8, No. 2, 2003, pp. 106-128.
W. E. Hardman, J. Munoz Jr. and I. L. Cameron, “Role of Lipid Peroxidation and Antioxidant Enzymes in Omega 3 Fatty Acids Induced Suppression of Breast Cancer Xenograft Growth in Mice,” Cancer Cell International, Vol. 2, No. 10, 2002, pp. 1-9. doi:10.1186/1475-2867-2-10
H. S. Black, “Photocarcinogenesis and Diet,” Federation Proceedings, Vol. 46, No. 5, 1987, pp. 1901-1905.
M. A. Fischer and H. S. Black, “Modification of Membrane Composition, Eicosanoid Metabolism, and Immunoresponsiveness by Dietary Omega-3 and Omega-6 Fatty Acid Sources, Modulators of Ultraviolet-Carcinogenesis,” Photochemistry and Photobiology, Vol. 54, No. 3, 1991, pp. 381-387. doi:10.1111/j.1751-1097.1991.tb02031.x
M. Qi, D. Z. Chen, K. Liu, et al., “n-6 Polyunsaturated Fatty Acids Increase Skin But Not Cervical Cancer in Human Papillomavirus 16 Transgenic Mice,” Cancer Research, Vol. 62, No. 2, 2002, pp. 433-436.
B. S. Mackie, L. E. Mackie, L. D. Curtin and D. J. Bourne, “Melanoma and Dietary Lipids,” Nutrition Cancer, Vol. 9, No. 4, 1987, pp. 219-226. doi:10.1080/01635588709513930
R. M. Dam, Z. Huang, E. Giovannucci, E. B. Rimm, D. J. Hunter, G. A. Colditz, M. J. Stampfer and W. C. Willett, “Diet and Basal Cell Carcinoma of the Skin in a Prospective Cohort of Men,” American Journal of Clinical Nutrition, Vol. 71, No. 1, 2000, pp. 135-141.
C. Bain, A. Green, V. Siskind, J. Alexander and P. Harvey, “Diet and Melanoma,” Vol. 3, No. 3, 2003, pp. 235-238.